{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:42:45Z","timestamp":1793216565244,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00347-020-01081-x","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T11:03:26Z","timestamp":1584961406000},"page":"389-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Retinoblastom","Retinoblastoma"],"prefix":"10.1007","volume":"117","author":[{"given":"N.","family":"Bornfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. E.","family":"Bechrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Biewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","volume":"1","author":"H Dimaras","year":"2015","unstructured":"Dimaras\u00a0H, Corson\u00a0TW, Cobrinik\u00a0D et\u00a0al (2015) Retinoblastoma. Nat Rev Dis Primers 1:15021","journal-title":"Nat Rev Dis Primers"},{"key":"1081_CR2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","volume":"93","author":"T Kivela","year":"2009","unstructured":"Kivela\u00a0T (2009) The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 93:1129\u20131131","journal-title":"Br J Ophthalmol"},{"key":"1081_CR3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/978-1-4419-6448-9_21","volume":"685","author":"D Lohmann","year":"2010","unstructured":"Lohmann\u00a0D (2010) Retinoblastoma. Adv Exp Med Biol 685:220\u2013227","journal-title":"Adv Exp Med Biol"},{"key":"1081_CR4","first-page":"A724","volume":"104","author":"M Gr\u00e4f","year":"2007","unstructured":"Gr\u00e4f\u00a0M (2007) Fr\u00fcherkennung von Sehst\u00f6rungen bei Kindern. Durchleuchtungstest nach Br\u00fcckner \u2013 Ein Muss bei allen Vorsorgeuntersuchungen im Kindesalter. Dtsch Arztebl 104:A724\u2013A729","journal-title":"Dtsch Arztebl"},{"key":"1081_CR5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.sjopt.2013.06.006","volume":"27","author":"KP Jijelava","year":"2013","unstructured":"Jijelava\u00a0KP, Grossniklaus\u00a0HE (2013) Diffuse anterior retinoblastoma: a review. Saudi J Ophthalmol 27:135\u2013139","journal-title":"Saudi J Ophthalmol"},{"key":"1081_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/bjophthalmol-2011-300051","volume":"96","author":"AP Moulin","year":"2012","unstructured":"Moulin\u00a0AP, Gaillard\u00a0MC, Balmer\u00a0A et\u00a0al (2012) Ultrasound biomicroscopy evaluation of anterior extension in retinoblastoma: a\u00a0clinicopathological study. Br J Ophthalmol 96:337\u2013340","journal-title":"Br J Ophthalmol"},{"key":"1081_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/eye.2010.193","volume":"25","author":"LM Vasquez","year":"2011","unstructured":"Vasquez\u00a0LM, Giuliari\u00a0GP, Halliday\u00a0W et\u00a0al (2011) Ultrasound biomicroscopy in the management of retinoblastoma. Eye (Lond) 25:141\u2013147","journal-title":"Eye (Lond)"},{"key":"1081_CR8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiol.2015151213","volume":"279","author":"MC De Jong","year":"2016","unstructured":"De Jong\u00a0MC, Van Der Meer\u00a0FJ, Goricke\u00a0SL et\u00a0al (2016) Diagnostic accuracy of Intraocular tumor size measured with MR imaging in the prediction of postlaminar optic nerve invasion and massive choroidal invasion of retinoblastoma. Radiology 279:817\u2013826","journal-title":"Radiology"},{"key":"1081_CR9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00247-012-2576-y","volume":"43","author":"S Sirin","year":"2013","unstructured":"Sirin\u00a0S, Schlamann\u00a0M, Metz\u00a0KA et al (2013) Diagnostic image quality of gadolinium-enhanced T1-weighted MRI with and without fat saturation in children with retinoblastoma. Pediatr Radiol 43:716\u2013724","journal-title":"Pediatr Radiol"},{"key":"1081_CR10","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1136\/bjophthalmol-2014-305180","volume":"98","author":"JW Kim","year":"2014","unstructured":"Kim\u00a0JW, Ngai\u00a0LK, Sadda\u00a0S et\u00a0al (2014) Retcam fluorescein angiography findings in eyes with advanced retinoblastoma. Br J Ophthalmol 98:1666\u20131671","journal-title":"Br J Ophthalmol"},{"key":"1081_CR11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ophtha.2011.09.040","volume":"119","author":"C Bianciotto","year":"2012","unstructured":"Bianciotto\u00a0C, Shields\u00a0CL, Iturralde\u00a0JC et al (2012) Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma. Ophthalmology 119:843\u2013849","journal-title":"Ophthalmology"},{"key":"1081_CR12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0002-9394(14)77372-6","volume":"93","author":"Y Ohnishi","year":"1982","unstructured":"Ohnishi\u00a0Y, Yamana\u00a0Y, Minei\u00a0M et\u00a0al (1982) Application of fluorescein angiography in retinoblastoma. Am J Ophthalmol 93:578\u2013588","journal-title":"Am J Ophthalmol"},{"key":"1081_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/13816810.2018.1436183","volume":"39","author":"MC Gaillard","year":"2018","unstructured":"Gaillard\u00a0MC, Houghton\u00a0S, Stathopoulos\u00a0C et al (2018) OCT-guided management of subclinical recurrent retinoblastoma. Ophthalmic Genet 39:338\u2013343","journal-title":"Ophthalmic Genet"},{"key":"1081_CR14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/bjophthalmol-2018-312546","volume":"103","author":"C Stathopoulos","year":"2019","unstructured":"Stathopoulos\u00a0C, Moulin\u00a0A, Gaillard\u00a0MC et al (2019) Conservative treatment of diffuse infiltrating retinoblastoma: optical coherence tomography-assisted diagnosis and follow-up in three consecutive cases. Br J Ophthalmol 103:826\u2013830","journal-title":"Br J Ophthalmol"},{"key":"1081_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/13816810802452168","volume":"30","author":"DE Novetsky","year":"2009","unstructured":"Novetsky\u00a0DE, Abramson\u00a0DH, Kim\u00a0JW et\u00a0al (2009) Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies\u2014an analysis of impact. Ophthalmic Genet 30:40\u201344","journal-title":"Ophthalmic Genet"},{"key":"1081_CR16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.icu.0000193079.55240.18","volume":"17","author":"CL Shields","year":"2006","unstructured":"Shields\u00a0CL, Shields\u00a0JA (2006) Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17:228\u2013234","journal-title":"Curr Opin Ophthalmol"},{"key":"1081_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10143-017-0890-4","volume":"42","author":"R Yamanaka","year":"2019","unstructured":"Yamanaka\u00a0R, Hayano\u00a0A, Takashima\u00a0Y (2019) Trilateral retinoblastoma: a systematic review of 211 cases. Neurosurg Rev 42:39\u201348","journal-title":"Neurosurg Rev"},{"key":"1081_CR18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1055\/s-0041-102899","volume":"232","author":"S Schlueter","year":"2015","unstructured":"Schlueter\u00a0S, Metz\u00a0K, Bornfeld\u00a0N et\u00a0al (2015) Intraokulare Raumforderungen im Kindesalter ohne Retinoblastom. Klin Monbl Augenheilkd 232:838\u2013844","journal-title":"Klin Monbl Augenheilkd"},{"key":"1081_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ophtha.2012.07.067","volume":"120","author":"CL Shields","year":"2013","unstructured":"Shields\u00a0CL, Schoenberg\u00a0E, Kocher\u00a0K et\u00a0al (2013) Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Ophthalmology 120:311\u2013316","journal-title":"Ophthalmology"},{"key":"1081_CR20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/IAE.0000000000001399","volume":"37","author":"AL Daruich","year":"2017","unstructured":"Daruich\u00a0AL, Moulin\u00a0AP, Tran\u00a0HV et\u00a0al (2017) Subfoveal nodule in coats\u2019 disease: toward an updated classification predicting visual prognosis. Retina 37:1591\u20131598","journal-title":"Retina"},{"key":"1081_CR21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/13816810.2016.1199715","volume":"38","author":"SE Soliman","year":"2017","unstructured":"Soliman\u00a0SE, Wan\u00a0MJ, Heon\u00a0E et\u00a0al (2017) Retinoblastoma versus advanced Coats\u2019 disease: Is enucleation the answer? Ophthalmic Genet 38:291\u2013293","journal-title":"Ophthalmic Genet"},{"key":"1081_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.8.2.13","volume":"8","author":"BK Ghiam","year":"2019","unstructured":"Ghiam\u00a0BK, Xu\u00a0L, Berry\u00a0JL (2019) Aqueous humor markers in retinoblastoma, a\u00a0review. Transl Vis Sci Technol 8:13","journal-title":"Transl Vis Sci Technol"},{"key":"1081_CR23","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jamaophthalmol.2017.4600","volume":"135","author":"JH Francis","year":"2017","unstructured":"Francis\u00a0JH, Abramson\u00a0DH, Ji\u00a0X et\u00a0al (2017) Risk of Extraocular extension in eyes with retinoblastoma receiving Intravitreous chemotherapy. JAMA Ophthalmol 135:1426\u20131429","journal-title":"JAMA Ophthalmol"},{"key":"1081_CR24","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","volume":"23","author":"RA Kleinerman","year":"2005","unstructured":"Kleinerman\u00a0RA, Tucker\u00a0MA, Tarone\u00a0RE et al (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J\u00a0Clin Oncol 23:2272\u20132279","journal-title":"J Clin Oncol"},{"key":"1081_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.26193","volume":"64","author":"P Temming","year":"2017","unstructured":"Temming\u00a0P, Arendt\u00a0M, Viehmann\u00a0A et\u00a0al (2017) Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: a report from the German reference center. Pediatr Blood Cancer 64:71\u201380","journal-title":"Pediatr Blood Cancer"},{"key":"1081_CR26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cncr.28387","volume":"120","author":"RV Sethi","year":"2014","unstructured":"Sethi\u00a0RV, Shih\u00a0HA, Yeap\u00a0BY et\u00a0al (2014) Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer 120:126\u2013133","journal-title":"Cancer"},{"key":"1081_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","volume":"13","author":"American Brachytherapy Society\u2014Ophthalmic Oncology Task Force","year":"2014","unstructured":"American Brachytherapy Society\u2014Ophthalmic Oncology Task Force (2014) The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy 13:1\u201314","journal-title":"Brachytherapy"},{"key":"1081_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bjophthalmol-2019-313985","volume":"104","author":"JJ Echegaray","year":"2020","unstructured":"Echegaray JJ, Al-Zahrani YA, Singh\u00a0A (2020) Episcleral brachytherapy for retinoblastoma. Br J Ophthalmol 104:208\u2013213","journal-title":"Br J Ophthalmol"},{"key":"1081_CR29","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ijrobp.2006.02.002","volume":"65","author":"AO Schueler","year":"2006","unstructured":"Schueler\u00a0AO, Fluhs\u00a0D, Anastassiou\u00a0G et al (2006) Beta-ray brachytherapy with 106Ru plaques for retinoblastoma. Int J Radiat Oncol Biol Phys 65:1212\u20131221","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1081_CR30","first-page":"CD012366","volume":"6","author":"ID Fabian","year":"2017","unstructured":"Fabian\u00a0ID, Johnson\u00a0KP, Stacey\u00a0AW et\u00a0al (2017) Focal laser treatment in addition to chemotherapy for retinoblastoma. Cochrane Database Syst Rev 6:CD12366","journal-title":"Cochrane Database Syst Rev"},{"key":"1081_CR31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12885-018-4406-6","volume":"18","author":"Q Chen","year":"2018","unstructured":"Chen\u00a0Q, Zhang\u00a0B, Dong\u00a0Y et al (2018) Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a\u00a0meta-analysis. BMC Cancer 18:486","journal-title":"BMC Cancer"},{"key":"1081_CR32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0002-9394(64)91368-6","volume":"58","author":"EB Dunphy","year":"1964","unstructured":"Dunphy\u00a0EB (1964) The story of retinoblastoma. The Xx Edward Jackson memorial lecture. Am J Ophthalmol 58:539\u2013552","journal-title":"Am J Ophthalmol"},{"key":"1081_CR33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archopht.116.7.887","volume":"116","author":"NE Bechrakis","year":"1998","unstructured":"Bechrakis\u00a0NE, Bornfeld\u00a0N, Schueler\u00a0A et\u00a0al (1998) Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol 116:887\u2013893","journal-title":"Arch Ophthalmol"},{"key":"1081_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-003-0366-0","volume":"9","author":"S Suzuki","year":"2004","unstructured":"Suzuki\u00a0S, Kaneko\u00a0A (2004) Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 9:1\u20136","journal-title":"Int J Clin Oncol"},{"key":"1081_CR35","doi-asserted-by":"crossref","first-page":"e0197081","DOI":"10.1371\/journal.pone.0197081","volume":"13","author":"JH Francis","year":"2018","unstructured":"Francis\u00a0JH, Levin\u00a0AM, Zabor\u00a0EC et al (2018) Ten-year experience with ophthalmic artery chemosurgery: ocular and recurrence-free survival. PLoS ONE 13:e197081","journal-title":"PLoS ONE"},{"key":"1081_CR36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","volume":"134","author":"YA Yousef","year":"2016","unstructured":"Yousef\u00a0YA, Soliman\u00a0SE, Astudillo\u00a0PPP et al (2016) Intra-arterial chemotherapy for retinoblastoma: a systematic review. JAMA Ophthalmol 134:584\u2013591","journal-title":"JAMA Ophthalmol"},{"key":"1081_CR37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ophtha.2011.08.045","volume":"119","author":"WJ Muen","year":"2012","unstructured":"Muen\u00a0WJ, Kingston\u00a0JE, Robertson\u00a0F et al (2012) Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Ophthalmology 119:611\u2013616","journal-title":"Ophthalmology"},{"key":"1081_CR38","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/IAE.0000000000000190","volume":"34","author":"DE Maidana","year":"2014","unstructured":"Maidana\u00a0DE, Pellegrini\u00a0M, Shields\u00a0JA et\u00a0al (2014) Choroidal thickness after intraarterial chemotherapy for retinoblastoma. Retina 34:2103\u20132109","journal-title":"Retina"},{"key":"1081_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-315209","author":"EM Biewald","year":"2019","unstructured":"Biewald EM, Bornfeld N, Metz KA et al (2019) Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315209","journal-title":"Br J Ophthalmol"},{"key":"1081_CR40","doi-asserted-by":"crossref","first-page":"e72441","DOI":"10.1371\/journal.pone.0072441","volume":"8","author":"JH Francis","year":"2013","unstructured":"Francis\u00a0JH, Gobin\u00a0YP, Dunkel\u00a0IJ et\u00a0al (2013) Carboplatin +\/\u2212 topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma. PLoS ONE 8:e72441","journal-title":"PLoS ONE"},{"key":"1081_CR41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bjophthalmol-2017-310328","volume":"102","author":"LA Habib","year":"2018","unstructured":"Habib\u00a0LA, Francis\u00a0JH, Fabius\u00a0AW et al (2018) Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years. Br J Ophthalmol 102:272\u2013275","journal-title":"Br J Ophthalmol"},{"key":"1081_CR42","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjophthalmol-2018-312037","volume":"103","author":"DH Abramson","year":"2019","unstructured":"Abramson\u00a0DH, Ji\u00a0X, Francis\u00a0JH et\u00a0al (2019) Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds. Br J Ophthalmol 103:488\u2013493","journal-title":"Br J Ophthalmol"},{"key":"1081_CR43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","volume":"124","author":"JH Francis","year":"2017","unstructured":"Francis\u00a0JH, Brodie\u00a0SE, Marr\u00a0B et al (2017) Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience. Ophthalmology 124:488\u2013495","journal-title":"Ophthalmology"},{"key":"1081_CR44","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000903","volume":"36","author":"CL Shields","year":"2016","unstructured":"Shields\u00a0CL, Douglass\u00a0AM, Beggache\u00a0M et\u00a0al (2016) Intravitreous chemotherapy for active vitreous seeding from retinoblastoma: outcomes after 192 consecutive injections. The 2015 Howard Naquin lecture. Retina 36:1184\u20131190","journal-title":"Retina"},{"key":"1081_CR45","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/IAE.0000000000002214","volume":"39","author":"S Kaliki","year":"2019","unstructured":"Kaliki\u00a0S, Taneja\u00a0S, Palkonda\u00a0VAR (2019) Inadvertent intraocular surgery in children with unsuspected retinoblastoma: a study of 14 cases. Retina 39:1794\u20131801","journal-title":"Retina"},{"key":"1081_CR46","doi-asserted-by":"crossref","first-page":"e1338","DOI":"10.1097\/MD.0000000000001338","volume":"94","author":"T Shen","year":"2015","unstructured":"Shen\u00a0T, Liu\u00a0R, Lin\u00a0J et\u00a0al (2015) Pars llana vitrectomy and evisceration resulting in death due to misdiagnosis of retinoblastoma in children: a review of 3 cases. Medicine (Baltimore) 94:e1338","journal-title":"Medicine (Baltimore)"},{"key":"1081_CR47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ophtha.2017.10.015","volume":"125","author":"J Zhao","year":"2018","unstructured":"Zhao\u00a0J, Li\u00a0Q, Wu\u00a0S et\u00a0al (2018) Pars plana vitrectomy and endoresection of refractory Intraocular retinoblastoma. Ophthalmology 125:320\u2013322","journal-title":"Ophthalmology"},{"key":"1081_CR48","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.ophtha.2018.02.028","volume":"125","author":"K Tripathy","year":"2018","unstructured":"Tripathy\u00a0K (2018) Re: Zhao et\u00a0al.: Pars plana vitrectomy and endoresection of refractory intraocular retinoblastoma (Ophthalmology. 2018;125:320\u2013322). Ophthalmology 125:e49\u2013e50","journal-title":"Ophthalmology"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01081-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-020-01081-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01081-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:25:02Z","timestamp":1616459102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-020-01081-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01081-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"23 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>N.\u00a0Bornfeld<\/b>: A.\u00a0Finanzielle Interessen: Honorar und Reisekosten: Fortbildungsveranstaltung der Fa.\u00a0Novartis (Makula-Update), 2015\u20132018. \u2013 Honorar f\u00fcr Advisory Board zur diabetischen Retinopathie, 2019: Fa.\u00a0Novartis. \u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Augenarzt, Universit\u00e4tsklinikum Essen (bis 29.02.2020) | Angestellter Augenarzt Praxis Prof.\u00a0Laube und Kollegen, D\u00fcsseldorf (seit 01.03.2019) | Mitgliedschaften: Deutsche Ophthalmologische Gesellschaft, Retinologische Gesellschaft, Berufsverband der Augen\u00e4rzte. <b>D.\u00a0Lohmann<\/b>: A. Finanzielle Interessen: Projektf\u00f6rderung: Deutsche Krebshilfe, Kinderaugenkrebsstiftung. \u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u00e4. an einer im Medizinbereich aktiven Firma: ja, ohne Angabe (kein Bezug zu diesem Beitrag). \u2013 B.\u00a0Nichtfinanzielle Interessen: Universit\u00e4tsprofessor, Universit\u00e4t Duisburg-Essen | Akkreditierungsbegutachter der Deutschen Akkreditierungsstelle. <b>N.E.\u00a0Bechrakis<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Novartis, Bayer. Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Alcon. Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u2009\u00c4.: ohne Angabe (kein Bezug auf das hier behandelte Thema). \u2013 B.\u00a0Nichtfinanzielle Interessen: Direktor, Klinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Essen, Deutschland. <b>E.\u00a0Biewald<\/b>: A.\u00a0Finanzielle Interessen: E.\u00a0Biewald gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Ophthalmologin der Universit\u00e4tsaugenklinik Essen (seit 2005), Ober\u00e4rztin mit dem Schwerpunkt Ophthalmoonkologie | Mitgliedschaften: DOG und ISOO (International Society of Ocular Oncology).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}